Ballroom
Panel Discussion #2 - Legislation and regulation - health and economic consequences
16:00 - 17:30 (Europe/Warsaw)
An examination of the health and economic impact of tobacco control measures and the role for proportionate regulation and risk management for alternative nicotine products.
Host
Clive Bates
Panellist
Dave Sweanor
Dave Sweanor
- Panellist
- Canada
David Sweanor is an adjunct professor, Faculty of Law, and chair of the advisory board of the Centre for Health Law, Policy & Ethics at the University of Ottawa and has been actively involved in tobacco and health policy issues since the beginning of the 1980s. He has worked globally, and with numerous groups, including the International Union Against Cancer, World Health Organization, World Bank and the Pan American Health Organization and played a key role in achieving many global precedents in tobacco policy. He currently focuses much of his tobacco and nicotine related efforts on risk reduction strategies.
Panellist
Stefanie Miller
Stefanie Miller
- Panellist
- United States of America
Stefanie Miller is vice president of external affairs at Juul Labs Inc. Prior to joining Juul Labs, Miller spent more than a decade as a Wall Street analyst with expertise in political and policy risk to financial markets and companies therein, including the nicotine and tobacco industries. Miller began her career working for a former U.S. senator from her home state of Nebraska. She received her Master of Business Administration degree from Georgetown University and her Bachelor of Arts degree in economics and political science from the University of Nebraska.
Panellist
Konstantinos Farsalinos
Konstantinos Farsalinos
- Panellist
- Greece
Konstantinos Farsalinos, MD, MPH, is a physician and a research associate at the University of Patras and the University of West Attica in Greece. His field of expertise is Public Health. He has been conducting laboratory, clinical and epidemiological research on smoking, tobacco harm reduction and nicotine products as principal investigator since 2011. He authored the first systematic review on e-cigarette safety/risk profile, published in 2014. Additionally, he has performed research and published studies on heated tobacco products. His findings have been presented in major international scientific congresses and his studies were used in preparing the regulatory framework on e-cigarettes by the European Union in 2014. As of early 2024, he has published more than 100 studies and articles in international peer-reviewed scientific journals, mostly about smoking, tobacco harm reduction and alternative-to-smoking nicotine products. He has presented in more than 80 international conferences and he was the handling editor and author of a book titled "Analytical assessment of e-cigarettes", published by Elsevier in 2017. In November 2020, he was declared a Highly Cited Researcher 2019 by the Web of Science, a list of researchers (6200 scientists out of 9 million examined) with the highest impact in global science in 21 scientific fields in the past decade. During the COVID-19 pandemic, he has published 10 peer-reviewed articles and several pre-prints about COVID-19, including the association between smoking, nicotine and COVID-19.
Panellist
Joe Thompson